Author name: Leonardo Arias

Un nuevo sistema de inteligencia artificial ha demostrado que es capaz de localizar y estimar la extensión de las alteraciones del tejido asociadas a la cardiomiopatía auricular a partir de registros eléctricos obtenidos sobre la superficie corporal.   El sistema es obra …

The state has expanded its controversial healthcare AI program with three new pilots that could ultimately see the technology provide care plans and medications without human review.

Cook Medical has become Zenflow’s U.S. distributor in a urology device market targeted by Boston Scientific, Olympus and Teleflex.

Regulators warned two dozen hospital systems that incomplete or misleading pricing disclosures could violate federal consumer protection laws.

From AdvaMed’s meeting in San Francisco to a robotics conference in Rome, next year’s calendar is already filled with medtech events to attend.

BD plans to increase U.S. production of essential medical consumables in exchange for relief from future tariffs on its products.

Lobo will step down on Dec. 31 as CEO after more than 15 years at Stryker. Chief operating officer Spencer Stiles will lead the company.

AbbVie and Genmab’s bispecific antibody blew analyst expectations out of the water with a 51% improvement in progression-free survival when used alongside a standard frontline regimen in diffuse large B cell lymphoma—potentially setting up a battle with Roche’s Polivy.

Despite the regulatory delay, Novo is still expecting a 2027 launch for its hemophilia A drug denecimig.

With its acquisition of IntraBio, Shionogi will gain ownership over Aqneursa, which could hit peak global sales of $1 billion across its two indications in Niemann-Pick disease type C and ataxia-telangiectasia, according to Jefferies.